Healthcare - Biotechnology - NASDAQ - US
$ 1.0
0 %
$ 29.8 M
Market Cap
-0.5
P/E
Price Target
Average
333.33%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
41.88%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
AN2 Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ANTX of $4.33 , with forecasts ranging from a low of $2 to a high of $6 .
ANTX Lowest Price Target
Wall Street Target
2 USD
100.00%
ANTX Average Price Target
Wall Street Target
4.33 USD
333.33%
ANTX Highest Price Target
Wall Street Target
6 USD
500.00%
REVENUE FORECAST
Revenue Forecast Chart ANTX
EBIT FORECAST
EBIT Forecast Chart ANTX
NET INCOME FORECAST
Net Income Chart ANTX